Utility of the Millon Behavioral Medicine Diagnostic to Predict Medication Adherence in Patients Diagnosed with Heart Failure

  • Kristen Farrell
  • Biing-Jiun Shen
  • Stephen Mallon
  • Frank J. Penedo
  • Michael H. Antoni


Medication non-adherence is common and a primary reason for poor medical outcomes among individuals with heart failure (HF). This study’s aims were to determine whether depression, hostility, and the personality-based Millon Behavioral Medicine Diagnostic (MBMD) Medication Abuse scale were associated with medication adherence (e.g., beta-blockers, ACE inhibitors, diuretics, statins) beyond contributions of demographic, medical, and psychosocial variables in an ethnically-diverse sample of 105 men and women diagnosed with HF. In hierarchical regression, greater MBMD Medication Abuse scale scores were associated with poorer adherence above and beyond both depression (β = .236, t[102] = 2.113, p = .037) and hostility (β = .244, t[102] = 2.506, p = .014). The Medication Abuse scale also completely mediated the relationship between adherence and depression. These findings suggest that personality measures such as the MBMD and hostility scales might be utilized in future studies investigating predictors of adherence and also used clinically to predict medication adherence among HF patients.


Adherence Heart failure Personality Depression 


  1. American Heart Association (2002) Heart Disease and Stroke Statistics-2002 Update. Dallas, TX.Google Scholar
  2. American Heart Association (2005) Heart Disease and Stroke Statistics-2005 Update. Dallas, TX.Google Scholar
  3. Bane, C., Hughes, C. M., & McElnay, J. C. (2006). The impact of depressive symptoms and psychosocial factors on medication adherence in cardiovascular disease. Patient Education and Counseling, 60, 187–193.PubMedCrossRefGoogle Scholar
  4. Baron, R. M., & Kenny, D. A. (1986). The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. Journal of Personality and Social Psychology, 51, 1173–1182.PubMedCrossRefGoogle Scholar
  5. Chapman, R. H., Benner, J. S., Petrilla, A. A., Tierce, J. C., Collins, S. R., Battleman, D. S., et al. (2005). Predictors of adherence with antihypertensive and lipid-lowering therapy. Archives of Internal Medicine, 165, 1147–1152.PubMedCrossRefGoogle Scholar
  6. Cook, W. W., & Medley, D. M. (1954). Proposed hostility and pharisaic-virtue scales for the MMPI. Journal of Applied Psychology, 38, 414–418.CrossRefGoogle Scholar
  7. Cramer, J. A., Mattson, R. H., Prevey, M. L., Scheyer, R. D., & Oulette, V. L. (1989). How often is medication taken as prescribed? A novel assessment technique. JAMA, 261, 3273–3277.PubMedCrossRefGoogle Scholar
  8. Cruess, D. G., Localio, R., Platt, A. B., Brensinger, C. M., Christie, J. D., Gross, R., et al. (2010). Patient attitudinal and behavioral factors associated with warfarin non-adherence at outpatient anticoagulation clinics. International Journal of Behavioral Medicine, 17, 33–42.PubMedCrossRefGoogle Scholar
  9. Cruess, D. G., Minor, S., Antoni, M. H., & Millon, T. (2007). Utility of the Millon Behavioral Medicine Diagnostic (MBMD) to predict adherence to highly active antiretroviral therapy (HAART) medication regimens among HIV-positive men and women. Journal of Personality Assessment, 89, 277–290.PubMedGoogle Scholar
  10. De Geest, S., Scheurweghs, L., Reynders, I., Pelemans, W., Droogné, W., Van Cleemput, J., et al. (2003). Differences in psychosocial and behavioral profiles between heart failure patients admitted to cardiology and geriatric wards. European Journal of Heart Failure, 5, 557–567.PubMedCrossRefGoogle Scholar
  11. Eagle, K. A., Kline-Rogers, E., Goodman, S. G., Gurfinkel, E. P., Avezum, A., Flather, M., et al. (2004). Adherence to evidence-based therapies after discharge for acute coronary syndromes: An ongoing prospective, observational study. American Journal of Medicine, 117, 73–81.PubMedCrossRefGoogle Scholar
  12. Erickson, S. R., Coombs, J. H., Kirking, D. M., & Azimi, A. R. (2001). Compliance from self-reported versus pharmacy claims data with metered-dose inhalers. Annals of Pharmacotherapy, 35, 997–1003.PubMedCrossRefGoogle Scholar
  13. Evangelista, L. S., Berg, J., & Dracup, K. (2001). Relationship between psychosocial variables and compliance in patients with heart failure. Heart and Lung, 30, 294–301.PubMedCrossRefGoogle Scholar
  14. George, J., & Shalansky, S. J. (2006). Predictors of refill non-adherence in patients with heart failure. British Journal of Clinical Pharmacology, 63, 488–493.PubMedCrossRefGoogle Scholar
  15. Granger, B. B., Swedberg, K., Ekman, I., Granger, C. B., Olofsson, B., McMurray, J. J., et al. (2005). Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: Double-blind, randomized, controlled clinical trial. Lancet, 366, 2005–2011.PubMedCrossRefGoogle Scholar
  16. Greenglass, E. R., & Julkunen, J. (1991). Cook-Medley hostility, anger, and the Type A behavior pattern in Finland. Psychological Reports, 68(3), 1059–1066.PubMedCrossRefGoogle Scholar
  17. Gwadry-Sridhar, F. H., Arnold, J. M., Zhang, Y., Brown, J. E., Marchiori, G., & Guyatt, G. (2005). Pilot study to determine the impact of a multidisciplinary educational intervention in patients hospitalized with heart failure. American Heart Journal, 150, 982.PubMedGoogle Scholar
  18. Hauptman, P. J. (2008). Medication adherence in heart failure. Heart Failure Reviews, 13, 99–106.PubMedCrossRefGoogle Scholar
  19. Holtgraves, T. (2004). Social desirability and self-reports: Testing models of socially desirable responding. Personality and Social Psychology Bulletin, 30, 161–172.PubMedCrossRefGoogle Scholar
  20. Horne, R., & Weinman, J. (1999). Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. Journal of Psychosomatic Research, 47, 555–567.PubMedCrossRefGoogle Scholar
  21. Horwitz, R. I., Viscoli, C. M., Berkman, L., Donaldson, R. M., Horwitz, S. M., Murray, C. J., et al. (1990). Treatment adherence and risk of death after a myocardial infarction. Lancet, 336, 542–545.PubMedCrossRefGoogle Scholar
  22. Hunt, S. A., Baker, D. W., Chin, M. H., Cinquegrani, M. P., Feldman, A. M., Francis, G. S., et al. (2002). ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: Executive summary. Journal of Heart and Lung Transplant, 21, 189–203.CrossRefGoogle Scholar
  23. Hunt, H. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., et al. American College of Cardiology; American Heart Association Task Force on Practice Guidelines; American College of Chest Physicians; International Society for Heart and Lung Transplantation; Heart Rhythm Society. (2005). Update for the diagnosis and management of chronic heart failure in the adult: Summary article. Circulation, 112, 1825–1852.Google Scholar
  24. Kawachi, I., Sparrow, D., Spiro, A. I., Vokonas, P., & Weiss, S. T. (1995). A prospective study of anger and coronary heart disease: The Normative Aging Study. Circulation, 84, 2090–2095.Google Scholar
  25. Khanderia, U., Townsend, K. A., Erickson, S. R., Vlasnik, J., Prager, R. L., & Eagle, K. A. (2008). Medication adherence following coronary artery bypass graft surgery: Assessment of beliefs and attitudes. Annals of Pharmacotherapy, 42, 192–199.PubMedCrossRefGoogle Scholar
  26. Kramer, J. M., Hammill, B., Anstrom, K. J., Fetterolf, D., Snyder, R., Charde, J. P., et al. (2006). National evaluation of adherence to beta-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance. American Heart Journal, 152, 1–8.CrossRefGoogle Scholar
  27. Krumholz, H. M., Amatruda, J., Smith, G. L., Mattera, J. A., Roumanis, S. A., Radford, M. J., et al. (2002). Randomized trial of an education and support intervention to prevent readmission of patients with heart failure. Journal of American College of Cardiology, 39, 83–89.CrossRefGoogle Scholar
  28. Krumholz, H. M., Parent, E. M., Tu, N., Vaccarino, V., Wang, Y., Radford, M. J., et al. (1997). Readmission after hospitalization for congestive heart failure among medicare beneficiaries. Archives of Internal Medicine, 157, 99–104.PubMedCrossRefGoogle Scholar
  29. Lamb, D. A., Eurich, D. T., McAlister, F. A., Tsuyuki, R. T., Semchuk, W. M., Wilson, T. W., et al. (2009). Changes in adherence to evidence-based medications in the first year after initial hospitalization for heart failure: Observational cohort study from 1994 to 2003. Circulation: Cardiovascular Quality and Outcomes, 2, 229–235.CrossRefGoogle Scholar
  30. Maguire, L. K., Hughes, C. M., & McElnay, J. C. (2008). Exploring the impact of depressive symptoms and medication beliefs on medication adherence in hypertension—a primary care study. Patient Education and Counseling, 73, 371–376.PubMedCrossRefGoogle Scholar
  31. McAlister, F. A., Man-Son-Hing, M., Straus, S. E., Ghali, W. A., Gibson, P., Anderson, D., et al. (2004). A randomized trial to assess the impact of an antrithrombotic decision aid in patients with nonvalvular atrial fibrillation: The DAAFI trial protocol (ISRCTNI4429643). BMC Cardiovascular Disorders, 4, 5.PubMedCrossRefGoogle Scholar
  32. McDonald, H. P., Garg, A. X., & Haynes, R. B. (2002). Interventions to enhance patient adherence to medication prescriptions. JAMA, 288, 2868–2879.PubMedCrossRefGoogle Scholar
  33. Michalsen, A., Konig, G., & Thimme, W. (1998). Preventable causative factors leading to hospital admission with decompensated heart failure. Heart, 80(5), 437–441.PubMedGoogle Scholar
  34. Miller, T. Q., Smith, T. W., Turner, C. W., Guijarro, M. L., & Hallet, A. J. (1996). A meta-analytic review of research on hostility and physical health. Psychological Bulletin, 119, 322–348.PubMedCrossRefGoogle Scholar
  35. Millon, T., Antoni, M., Millon, C., Meagher, S., & Grossman, S. (2001). Millon Behavioral Medicine Diagnostic. Minneapolis, MN: NCS Assessments.Google Scholar
  36. Miura, T., Kojima, R., Mizutani, M., Shiga, Y., Takatsu, F., & Suzuki, Y. (2001). Effect of digoxin noncompliance on hospitalization and mortality in patients with heart failure in long-term therapy: A prospective cohort study. European Journal of Clinical Pharmacology, 57, 77–83.PubMedCrossRefGoogle Scholar
  37. Morgan, A. L., Masoudi, F. A., Havranek, E. P., Jones, P. G., Peterson, P. N., Drumholz, H. M., et al.; for the Cardiovascular outcomes research consortium. (2006). Difficulty taking medications, depression, and health status in heart failure patients. Journal of Cardiac Failure, 12, 54–60.Google Scholar
  38. Morisky, D. E., Green, L. W., & Levine, D. M. (1986). Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care, 24, 67–74.PubMedCrossRefGoogle Scholar
  39. Ni, H., Nauman, D., Burgess, D., Wise, K., Crispell, K., & Hershberger, R. E. (1999). Factors influencing knowledge of and adherence to self-care among patients with heart failure. Archives of Internal Medicine, 159, 1613–1619.PubMedCrossRefGoogle Scholar
  40. Opasich, C., Rapezzi, C., Lucci, D., Gorini, M., Pozzar, F., Zanelli, E., et al.; Italian Network on Congestive Heart Failure (IN-CHF) Investigators. (2001). Precipitating factors and decision-making processes of short-term worsening in heart failure despite “optimal” treatment (from the IN-CHF Registry). American Journal of Cardiology, 88, 382–387.Google Scholar
  41. Pamboukian, S. V., Nisar, I., Patel, S., Gu, L., McLeod, M., Costanzo, M. R., et al. (2008). Factors associated with non-adherence to therapy with warfarin in a population of chronic heart failure patients. Clinical Cardiology, 31, 30–34.PubMedCrossRefGoogle Scholar
  42. Park, D. C., Willis, S. L., Morrow, D., Diehl, M., & Gaines, C. L. (1994). Cognitive function and medication usage in older adults. Journal of Applied Gerontology, 13, 39–57.CrossRefGoogle Scholar
  43. Pearson, C. R., Simoni, J. M., Hoff, P., Kurth, A. E., & Martin, D. P. (2007). Assessing antiretroviral adherence via electronic drug monitoring and self-report: An examination of key methodological issues. AIDS and Behavior, 11, 161–173.PubMedCrossRefGoogle Scholar
  44. Phatak, H. M., & Thomas, J., I. I. I. (2006). Relationships between beliefs about medications and nonadherence to prescribed chronic medications. American Pharmacotherapy, 40, 1737–1742.CrossRefGoogle Scholar
  45. Radloff, L. S. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1, 385–401.CrossRefGoogle Scholar
  46. Rasmussen, J. N., Chong, A., & Alter, D. A. (2007). Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA, 297, 177–186.PubMedCrossRefGoogle Scholar
  47. Rich, M. W., Gray, D. B., Beckham, V., Wittenberg, C., & Luther, P. (1996). Effect of a multidisciplinary intervention on medication compliance in elderly patients with congestive heart failure. American Journal of Medicine, 101, 270–276.PubMedCrossRefGoogle Scholar
  48. Rich, M. W., Vinson, J. M., Sperry, J. C., Shah, A. S., Spinner, L. R., Chung, M. K., et al. (1993). Prevention of readmission in elderly patients with congestive heart failure: Results of a prospective, randomized pilot study. Journal of General Internal Medicine, 8, 585–590.PubMedCrossRefGoogle Scholar
  49. Schwarz, K. A., & Elman, C. S. (2003). Identification of factors predictive of hospital readmissions for patients with heart failure. Heart and Lung, 32, 88–99.PubMedCrossRefGoogle Scholar
  50. Shalansky, S. J., & Levy, A. R. (2002). Effect of the number of medications on cardiovascular therapy adherence. Annals of Pharmacotherapy, 36, 1532–1539.PubMedCrossRefGoogle Scholar
  51. Sherbourne, C. D., & Stewart, A. L. (1991). The MOS Social Support Survey. Social Science Medicine, 32, 705–714.PubMedCrossRefGoogle Scholar
  52. Simpson, R. J., Jr. (2006). Challenges for improving medication adherence. JAMA, 296, 2614–2616.PubMedCrossRefGoogle Scholar
  53. Soumerai, S. B., Pierre-Jacques, M., Zhang, F., Ross-Degnan, D., Adams, A. S., Gurwitz, J., et al. (2006). Cost-related medication non-adherence among elderly and disabled medicare beneficiaries: A national survey 1 year before the medicare drug benefit. Archives of Internal Medicine, 166, 1829–1835.PubMedCrossRefGoogle Scholar
  54. Stafford, L., Jackson, H. J., & Berk, M. (2008). Illness beliefs about heart disease and adherence to secondary prevention regimens. Psychosomatic Medicine, 70, 942–948.PubMedCrossRefGoogle Scholar
  55. Stephenson, B. J., Rowe, B. H., Haynes, R. B., Macharia, W. M., & Leon, G. (1993). The rational clinical examination. Is this patient taking the treatment as prescribed? JAMA, 269, 2779–2781.PubMedCrossRefGoogle Scholar
  56. Turki, A. K., & Sulaiman, S. A. S. (2009). Adherence to antihypertensive therapy in general hospital of Penang: Does daily dose frequency matter? Jordan Journal of Pharmaceutical Sciences, 2, 167–176.Google Scholar
  57. van der Wal, H. L., Jaarsma, T., Moser, D. K., Veeger, N. J. G. M., van Gilst, W. H., & van Veldhuisen, D. J. (2006). Compliance in heart failure patients: the importance of knowledge and beliefs. European Heart Journal, 27, 434–440.PubMedGoogle Scholar
  58. Vik, S. A., Maxwell, C. J., Hogan, D. B., Patten, S. B., Johnson, J. A., & Romonko-Slack, L. (2005). Canadian Journal of Clinical Pharmacology, 12, e152–e164.Google Scholar
  59. Vinson, J. M., Rich, M. W., Sperry, J. C., Shah, A. S., & McNamara, T. (1990). Early readmission of elderly patients with congestive heart failure. Journal of the American Geriatric Society, 38, 1290–1295.Google Scholar
  60. Wray, J., Waters, S., Radley-Smith, R., & Sensky, T. (2006). Adherence in adolescents and young adults following heart or heart-lung transplantation. Pediatric Transplantation, 10, 694–700.PubMedCrossRefGoogle Scholar
  61. Wu, J. R., Moser, D. K., Chung, M. L., & Lennie, T. A. (2008). Objectively measured, but not self-reported, medication adherence independently predicts event-free survival in patients with heart failure. Journal of Cardiac Failure, 14, 203–210.PubMedCrossRefGoogle Scholar
  62. Wu, J. R., Moser, D. K., DeJong, M. J., Rayens, M. K., Chung, M. L., Riegel, B., et al. (2009). Defining an evidence-based cutpoint for medication adherence in heart failure. American Heart Journal, 157, 285–291.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Kristen Farrell
    • 1
  • Biing-Jiun Shen
    • 2
  • Stephen Mallon
    • 3
  • Frank J. Penedo
    • 1
  • Michael H. Antoni
    • 1
  1. 1.Department of PsychologyUniversity of MiamiCoral GablesUSA
  2. 2.Department of PsychologyUniversity of Southern CaliforniaLos AngelesUSA
  3. 3.Miller School of MedicineUniversity of MiamiMiamiUSA

Personalised recommendations